Lucid Previews VivaNet(TM) Telemedicine Server For Dermatology Applications

Lucid, Inc. has previewed its
VivaNet(TM) telemedicine server for dermatology applications. The
VivaNet(TM) server is intended to link dermatology practitioners using
Lucid's non- invasive VivaScope(R) confocal imagers with other
dermatologists or pathologists via the Internet.


"Lucid's non-invasive VivaScope(R) confocal microscopes provide
cellular resolution images of skin that may be used by a dermatologist to
assist in forming a clinical judgment for a variety of skin conditions,"
said Jay Eastman, Chairman and CEO of Lucid, Inc. He continued,
"VivaNet(TM) is intended to provide fast, accurate, and secure storage,
retrieval and transfer of VivaScope(R) digital cellular resolution images
across the Internet to facilitate professional collaboration and
consultation."



During a typical VivaScope(R) imaging session, both dermatoscopic
quality, full color macroscopic pictures and microscopic, cellular
resolution images of the patient's skin are imaged. Once all of the images
for a single session are completed, the images and patient related data are
transferred for storage to the secure VivaNet(TM) server and are
immediately available for retrieval by and transfer to other authorized
practitioners for their review and collaboration.



VivaNet(TM) is an Internet-based, DICOM-compliant application that
enables the transfer of VivaScope(R) digital images between practitioners
and pathologists for rapid review of confocal images. DICOM, which is an
acronym for Digital Imaging and Communications in Medicine, is an
internationally accepted, and widely used open standard for the storage,
retrieval and transfer of medical images. HIPAA-compliance, privacy, and
data integrity are assured by using proven DICOM compliant software modules
that incorporate advanced encryption techniques.



"Our plan is that VivaNet(TM) will ultimately make in-vivo confocal
images available for review by other dermatologists and pathologists in
minutes, not days, thus enabling rapid, real-time professional
collaboration," said Eastman. "Lucid's ultimate goal is that practitioners
will rapidly receive a pathologic interpretation of confocal images from a
VivaScope(R) session, potentially assisting the practitioner in arriving at
a clinical judgment while the patient is still in the doctor's office."



Under a 3-year grant from the National Institute of Health's National
Cancer Institute, Lucid is conducting a five site clinical study to
determine the diagnostic accuracy of VivaScope(R) images for pigmented
lesions. Pilot studies of the procedure, published in 2004 - 2006,
demonstrated high sensitivity and specificity for VivaScope images when
read by a panel of diagnostic readers with relatively little training in
confocal image interpretation (30 to 60 minutes). This study will be
facilitated by the use of the VivaNet(TM) server.



"We are excited to introduce VivaNet(TM) to the dermatology community
and believe that the combination of Lucid's patented VivaScope(R) and
VivaNet(TM) technologies, that enable near real-time storage, retrieval and
communication of in-vivo confocal images, will ultimately bring these tools
into routine clinical use," said Eastman.



About Lucid, Inc.



Lucid Inc., based in Rochester, New York, is a medical device and
information company dedicated to creating innovative cellular imaging
technology and using the Internet to securely deliver accurate, real-time
VivaScope(R) cellular resolution images to medical professionals. The
Company's digital VivaNet(TM) server, coupled with its ability to image in-
vivo (living) tissue is envisioned to ultimately aid medical practitioners
and pathologists in screening for skin cancer and other dermatologic
conditions with clarity, speed and patient comfort. For more information,
visit Lucid-tech.


Lucid, Inc.

Lucid-tech